Synova Research
Retatrutide

⸺ Synova Research

Retatrutide

£80/ 10mg

Triple receptor agonist (GLP-1, GIP, glucagon) studied for weight management and metabolic regulation — researched in obesity and type 2 diabetes models.

Size

1

  • Independently tested

    COA on request

  • Next-day UK dispatch

    Order before 2pm

  • Research use only

    Not for human consumption

⸺ Important

  • • Bacteriostatic water not included
  • • Syringes not included
  • • Peptides sold in lyophilized form
  • • Strictly for laboratory research

You might also research

View all →
Tirzepatide

Tirzepatide

The dual agonist — targets both GLP-1 and GIP receptors, studied for weight management and blood sugar regulation in metabolic research.

10mgNext Day£70
Semaglutide

Semaglutide

The original GLP-1 — targets the GLP-1 receptor, studied for weight management and blood sugar regulation in metabolic research.

5mg£25
Cagrilintide

Cagrilintide

The appetite peptide — a long-acting amylin analogue studied for appetite regulation and weight management, researched alongside Retatrutide for combined effects.

10mg£50